Multicenter randomized controlled phase III study of nivolumab alone or in combination with ipilimumab as immunotherapy vs standard follow-up in surgically resectable HNSCC after adjuvant therapy

Mapping Intimacies ◽

10.1055/s-0040-1710984 ◽

2020 ◽

Author(s):

N Möckelmann ◽

M Binder ◽

CS. Betz ◽

Chia-Jung Busch

Keyword(s):

Adjuvant Therapy ◽

Phase Iii ◽

Randomized Controlled ◽

Phase Iii Study

Download Full-text

Multicenter randomized controlled phase III study of nivolumab alone or in combination with ipilimumab as immunotherapy vs. standard follow-up in surgical resectable HNSCC after adjuvant therapy

10.1055/s-0039-1685965 ◽

2019 ◽

Author(s):

C Betz ◽

M Binder ◽

A Münscher ◽

CJ Busch

Keyword(s):

Adjuvant Therapy ◽

Phase Iii ◽

Randomized Controlled ◽

Phase Iii Study

Download Full-text

Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-15-469 ◽

2014 ◽

Vol 15 (1) ◽

Author(s):

Barbara Burtness ◽

Jean P Bourhis ◽

Jan B Vermorken ◽

Kevin J Harrington ◽

Ezra EW Cohen

Keyword(s):

Randomized Controlled Trial ◽

Head And Neck Cancer ◽

High Risk ◽

Adjuvant Therapy ◽

Controlled Trial ◽

Phase Iii ◽

Double Blind ◽

Randomized Controlled ◽

Phase Iii Study ◽

Download Full-text

Randomized controlled phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – AGO DESKTOP III/ENGOT ov20

10.1055/s-0038-1671029 ◽

2018 ◽

Author(s):

P Harter ◽

J Sehouli ◽

W Meier ◽

A Reuss ◽

P Hillemanns ◽

...

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

Recurrent Ovarian Cancer ◽

Phase Iii ◽

Randomized Controlled ◽

Secondary Cytoreductive Surgery ◽

Phase Iii Study ◽

Download Full-text

ESPAC-4: A randomized controlled phase III trial of adjuvant gemcitabine (GEM) and capecitabine (CAP) versus gemcitabine in resected pancreatic ductal adenocarcinoma: five year follow up.

Pancreatology ◽

10.1016/j.pan.2020.07.393 ◽

2020 ◽

Vol 20 ◽

pp. S17-S18

Author(s):

J. Neoptolemos ◽

D. Palmer ◽

P. Gahneh ◽

J. Valle ◽

D. Cunningham ◽

...

Keyword(s):

Pancreatic Ductal Adenocarcinoma ◽

Phase Iii ◽

Ductal Adenocarcinoma ◽

Phase Iii Trial ◽

Randomized Controlled

Download Full-text

A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients

Drugs ◽

10.1007/s40265-021-01547-5 ◽

2021 ◽

Author(s):

Anil Gulati ◽

Rajat Choudhuri ◽

Ajay Gupta ◽

Saurabh Singh ◽

S. K. Noushad Ali ◽

...

Keyword(s):

Hypovolemic Shock ◽

Phase Iii ◽

Randomized Controlled ◽

Phase Iii Study

Download Full-text

High-protein intake and early exercise in adult intensive care patients: a randomized controlled phase III study to evaluate the impact on functional outcomes

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2021.09.289 ◽

2021 ◽

Vol 46 ◽

pp. S644

Author(s):

J. R. Araujo De Azevedo ◽

H. Lima ◽

P. Frota ◽

I. Nogueira ◽

S. Souza ◽

...

Keyword(s):

Intensive Care ◽

Functional Outcomes ◽

Protein Intake ◽

Phase Iii ◽

High Protein Intake ◽

Early Exercise ◽

Intensive Care Patients ◽

Randomized Controlled ◽

Phase Iii Study ◽

Download Full-text

KEYNOTE-522: Phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo + chemo as neoadjuvant followed by pembro vs placebo as adjuvant therapy for triple-negative breast cancer (TNBC)

Annals of Oncology ◽

10.1093/annonc/mdx364.015 ◽

2017 ◽

Vol 28 ◽

pp. v72 ◽

Author(s):

P. Schmid ◽

J. Cortes Castan ◽

J. Bergh ◽

L. Pusztai ◽

C. Denkert ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Iii ◽

Phase Iii Study

Download Full-text

Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

European Urology ◽

10.1016/j.eururo.2012.02.011 ◽

2012 ◽

Vol 61 (5) ◽

pp. 1062-1063 ◽

Author(s):

William M. Hilton ◽

Robert S. Svatek

Keyword(s):

Adjuvant Therapy ◽

Urothelial Cancer ◽

Locally Advanced ◽

Phase Iii ◽

Cancer Of The Bladder ◽

Phase Iii Study ◽

Advanced Urothelial Cancer

Download Full-text

P4-308: [18F]FLUTEMETAMOL AMYLOID PET IMAGING: OUTCOME OF A PHASE III STUDY IN SUBJECTS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT AFTER A 3-YEAR FOLLOW-UP

Alzheimer s & Dementia ◽

10.1016/j.jalz.2014.07.079 ◽

2014 ◽

Vol 10 ◽

pp. P898-P898 ◽

Author(s):

David A. Wolk ◽

Ranjan Duara ◽

Carl Sadowsky

Keyword(s):

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Pet Imaging ◽

Amnestic Mild Cognitive Impairment ◽

Phase Iii ◽

Amyloid Pet ◽

Phase Iii Study ◽

Amyloid Pet Imaging

Download Full-text

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

Contemporary Clinical Trials Communications ◽

10.1016/j.conctc.2020.100536 ◽

2020 ◽

Vol 17 ◽

pp. 100536 ◽

Author(s):

Christian Pfister ◽

Valentin Harter ◽

Yves Allory ◽

François Radvanyi ◽

Stéphane Culine ◽

...

Keyword(s):

Cell Cancer ◽

Locally Advanced ◽

Transitional Cell ◽

Phase Iii ◽

Randomized Controlled ◽

Cancer Of The Bladder ◽

Transitional Cell Cancer ◽

Phase Iii Study ◽

Gemcitabine And Cisplatin

Download Full-text